Table 4 Diagnostic accuracy of 18F-FDG PET/MRI and PET/CT from including studies
Imaging tool | Clinical settings | No. of studies (no. of patients) | Independent estimates | Likelihood ratio | AUC | ||
|---|---|---|---|---|---|---|---|
Sensitivity (95% CI) | Specificity (95% CI) | PLR (95% CI) | NLR (95% CI) | ||||
PET/MRI | All studies | 14(1042) | 0.87(0.77–0.93) | 0.97(0.93–0.98) | 25.1(12.1–52.1) | 0.13(0.07–0.24) | 0.98 |
PET/CT | All studies | 14(1042) | 0.81(0.70–0.88) | 0.97(0.92–0.99) | 23.1(9.5–56.0) | 0.20(0.13–0.32) | 0.95 |
PET/MRI | Lung cancer | 5(429) | 0.84(0.71–0.92) | 0.96(0.88–0.99) | 21.8(6.9–68.7) | 0.16(0.09–0.30) | 0.95 |
PET/CT | Lung cancer | 5(429) | 0.87(0.77–0.93) | 0.95(0.85–0.98) | 16.6(5.6–49.2) | 0.13(0.07–0.24) | 0.94 |
PET/MRI | Breast cancer | 3(182) | 0.95(0.87–0.99) | 0.96(0.90–0.97) | 15.9(4.2–60.6) | 0.09(0.03–0.24) | 0.98 |
PET/CT | Breast cancer | 3(182) | 0.87 (0.76–0.94) | 0.94 (0.88–0.98) | 11.1 (2.6–47.9) | 0.18(0.07–0.46) | 0.94 |